Olema Pharmaceuticals, Inc. OLMA

US Biotechnology

$7.40 ▲ +0.54% (+$0.04)

🔥 High Short Interest 🎢 High Beta

Open $7.21

Prev Close $7.36

Day Range $7.00 – $7.61

52W Range $6.24 – $36.26

Market Cap $643.98M

Beta 2.02

EPS (TTM) $-2.12

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-11-19
Shares Out.	87,500,000
Website	olema.com/ ↗
Phone	13026587581
Employees	150
Revenue	$0
Gross Profit	$0
Net Income	-$63.2M
Free Cash Flow	-$165.0M
Total Assets	$486.6M
Total Liabilities	$56.0M
Equity	$430.6M

About Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Olema Pharmaceuticals, Inc. is a publicly traded company under the ticker symbol OLMA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.